The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Whether intravenous thrombolysis is needed in combination with mechanical thrombectomy in patients with acute large vessel occlusion stroke is unclear. OBJECTIVE: To examine whether mechanical thrombectomy alone is noninferior to combined intravenous thrombolysis plus mechanical thrombectomy for favorable poststroke outcome. DESIGN, SETTING, AND PARTICIPANTS: Investigator-initiated, multicenter, randomized, open-label, noninferiority clinical trial in 204 patients with acute ischemic stroke due to large vessel occlusion enrolled at 23 hospital networks in Japan from January 1, 2017, to July 31, 2019, with final follow-up on October 31, 2019. INTERVENTIONS: Patients were randomly assigned to mechanical thrombectomy alone (n = 101) or combined intravenous thrombolysis (alteplase at a 0.6-mg/kg dose) plus mechanical thrombectomy (n = 103). MAIN OUTCOMES AND MEASURES: The primary efficacy end point was a favorable outcome defined as a modified Rankin Scale score (range, 0 [no symptoms] to 6 [death]) of 0 to 2 at 90 days, with a noninferiority margin odds ratio of 0.74, assessed using a 1-sided significance threshold of .025 (97.5% CI). There were 7 prespecified secondary efficacy end points, including mortality by day 90. There were 4 prespecified safety end points, including any intracerebral hemorrhage and symptomatic intracerebral hemorrhage within 36 hours. RESULTS: Among 204 patients (median age, 74 years; 62.7% men; median National Institutes of Health Stroke Scale score, 18), all patients completed the trial. Favorable outcome occurred in 60 patients (59.4%) in the mechanical thrombectomy alone group and 59 patients (57.3%) in the combined intravenous thrombolysis plus mechanical thrombectomy group, with no significant between-group difference (difference, 2.1% [1-sided 97.5% CI, -11.4% to ∞]; odds ratio, 1.09 [1-sided 97.5% CI, 0.63 to ∞]; P = .18 for noninferiority). Among the 7 secondary efficacy end points and 4 safety end points, 10 were not significantly different, including mortality at 90 days (8 [7.9%] vs 9 [8.7%]; difference, -0.8% [95% CI, -9.5% to 7.8%]; odds ratio, 0.90 [95% CI, 0.33 to 2.43]; P > .99). Any intracerebral hemorrhage was observed less frequently in the mechanical thrombectomy alone group than in the combined group (34 [33.7%] vs 52 [50.5%]; difference, -16.8% [95% CI, -32.1% to -1.6%]; odds ratio, 0.50 [95% CI, 0.28 to 0.88]; P = .02). Symptomatic intracerebral hemorrhage was not significantly different between groups (6 [5.9%] vs 8 [7.7%]; difference, -1.8% [95% CI, -9.7% to 6.1%]; odds ratio, 0.75 [95% CI, 0.25 to 2.24]; P = .78). CONCLUSIONS AND RELEVANCE: Among patients with acute large vessel occlusion stroke, mechanical thrombectomy alone, compared with combined intravenous thrombolysis plus mechanical thrombectomy, failed to demonstrate noninferiority regarding favorable functional outcome. However, the wide confidence intervals around the effect estimate also did not allow a conclusion of inferiority. TRIAL REGISTRATION: umin.ac.jp/ctr Identifier: UMIN000021488.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Cited by
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke
LeCouffe, N. E., Kappelhof, M., Treurniet, K. M., Rinkel, L. A., Bruggeman, A. E., Berkhemer, O. A., Wolff, L., van Voorst, H., Tolhuisen, M. L., Dippel, D. W. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107727 · Cited by 408
Fischer, U., Kaesmacher, J., Strbian, D., Eker, O., Cognard, C., Plattner, P. S., Bütikofer, L., Mordasini, P., Deppeler, S., Pereira, V. M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00537-2 · Cited by 291
Mitchell, P. J., Yan, B., Churilov, L., Dowling, R. J., Bush, S. J., Bivard, A., Huo, X. C., Wang, G., Zhang, S. Y., Ton, M. D., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00564-5 · Cited by 229
Metadata
- Authors
- Suzuki, K., Matsumaru, Y., Takeuchi, M., Morimoto, M., Kanazawa, R., Takayama, Y., Kamiya, Y., Shigeta, K., Okubo, S., Hayakawa, M., Ishii, N., Koguchi, Y., Takigawa, T., Inoue, M., Naito, H., Ota, T., Hirano, T., Kato, N., Ueda, T., Iguchi, Y., Akaji, K., Tsuruta, W., Miki, K., Fujimoto, S., Higashida, T., Iwasaki, M., Aoki, J., Nishiyama, Y., Otsuka, T., Kimura, K., & SKIP Study Investigators
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-01-19
- Volume
- 325
- Issue
- 3
- Pages
- 244
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3121615880
- Cited by
- 545
- References
- 1
- FWCI
- 64.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2020.23522
- The paper
- Suzuki, K., Matsumaru, Y., Takeuchi, M., Morimoto, M., Kanazawa, R., Takayama, Y., Kamiya, Y., Shigeta, K., Okubo, S., Hayakawa, M., Ishii, N., Koguchi, Y., Takigawa, T., Inoue, M., Naito, H., Ota, T., Hirano, T., Kato, N., Ueda, T., . . . SKIP Study Investigators. (2021). Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2020.23522
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.